![Ypke van Oosterhout](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Posizioni attive di Ypke van Oosterhout
Società | Posizione | Inizio | Fine |
---|---|---|---|
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Direttore/Membro del Consiglio | 01/01/2009 | - |
Amministratore Delegato | 01/01/2009 | - | |
Fondatore | 01/01/2009 | - |
Storia della carriera di Ypke van Oosterhout
Statistiche
Distribuzione geografica
Paesi Bassi | 2 |
Posizioni
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Xenikos BV
![]() Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands. | Health Technology |
- Borsa valori
- Insiders
- Ypke van Oosterhout
- Esperienza